Skip to main content
. 2021 Sep 1;25(5):101607. doi: 10.1016/j.bjid.2021.101607

Table 1.

Detection of antibodies by counterimmunoelectrophoresis and double immunodiffusion methods using a commercial antigen from Paracoccidioides spp.: evaluation of sera from patients with paracoccidioidomycosis or other diseases.

Detection of antibodies – N° of sera (%)
Disease type CIEP
DID
Total
Positive Negative Positive Negative
Paracoccidioidomycosis – active diseasea 24 (100) 0 (0) 15 (63) 9 (37) 24 (100)
Paracoccidioidomycosis in regression or clinical cureb 15 (88) 2 (12) 15 (88) 2 (12) 17 (100)
Histoplasmosis 0 (0) 7 (100) 0 (0) 7 (100) 7 (100)
Aspergillosis 0 (0) 5 (100) 0 (0) 5 (100) 5 (100)
Other diseasesc 0 (0) 27(100) 0 (0) 27 (100) 27 (100)
a

Patients without treatment or with up to three months of use of antifungals.

b

Patients with antifungal therapy higher than 3 months or already completed.

c

Patients without systemic fungal infection.

CIEP, counterimmunoelectrophoresis; DID, double immunodiffusion.